SPONSOR
University of Cologne
Total Trials
3
Recruiting
3
Phases
Phase 3
Conditions studied: Polycystic Kidney, Autosomal DominantInvasive Fungal DiseasePreterm BirthMother-Infant InteractionInfant Development
University of Cologne is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Polycystic Kidney, Autosomal Dominant, Invasive Fungal Disease, Preterm Birth, Mother-Infant Interaction.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Cologne
How many clinical trials has University of Cologne sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by University of Cologne, of which 3 are actively recruiting participants. These trials cover conditions including Polycystic Kidney, Autosomal Dominant, Invasive Fungal Disease, Preterm Birth. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Cologne research focus on?
University of Cologne clinical trials span Polycystic Kidney, Autosomal Dominant, Invasive Fungal Disease, Preterm Birth, Mother-Infant Interaction, Infant Development. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Cologne clinical trial?
To participate in a University of Cologne trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Cologne trials with current recruitment status updated daily.
Clinical Trials by University of Cologne
NCT07280585 Phase 3
Recruiting
STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease
Polycystic Kidney, Autosomal Dominant
NCT01731353
Recruiting
FungiScope - A Global Emerging Fungal Infection Registry
Invasive Fungal Disease
NCT05975203
Recruiting
Continuous Delivery Room Skin-to-skin-study for Moderate and Late Preterm Infants
Preterm Birth
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology